Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Olsson

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Lakartidningen|September 22, 2012
[Medical care for individuals with mental retardation--who takes responsibility?]Hans Olsson, Kent Thuresson, Per Algot Thorslund
Journal of Dermatological Science|January 22, 2005
Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcersFariba Nayeri, Hans Olsson, Curt Peterson, et al.
BJU International|May 24, 2021
Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancerStaffan Jahnson, Peter Söderkvist, Firas Aljabery, et al.
Neuroimage|December 17, 2002
Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457Zsolt Cselényi, Hans Olsson, Lars Farde, et al.
Clinical Breast Cancer|July 2, 2013
Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survivalIvan Shabo, Hans Olsson, Olle Stål, et al.
BJU International|July 6, 2023
Bladder cancer grading using the four-tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classificationsStaffan Jahnson, Georg Jancke, Hans Olsson, et al.
Scandinavian Journal of Urology|September 8, 2012
Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumoursHans Olsson, Per Hultman, Johan Rosell, et al.
Lakartidningen|December 7, 2007
[Results following implementation of PCI in Varmland. 30-day mortality after myocardial infarction halved]Tage Nilsson, Hans Olsson, Johan Lugnegård, et al.
International Journal of Cancer|July 8, 2009
Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival timeIvan Shabo, Hans Olsson, Xiao-Feng Sun, et al.
Scandinavian Journal of Urology and Nephrology|December 14, 2011
HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladderHans Olsson, Ing-Marie Fyhr, Per Hultman, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Lakartidningen|September 22, 2012
[Medical care for individuals with mental retardation--who takes responsibility?]Hans Olsson, Kent Thuresson, Per Algot Thorslund
Journal of Dermatological Science|January 22, 2005
Hepatocyte growth factor; expression, concentration and biological activity in chronic leg ulcersFariba Nayeri, Hans Olsson, Curt Peterson, et al.
BJU International|May 24, 2021
Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancerStaffan Jahnson, Peter Söderkvist, Firas Aljabery, et al.
Neuroimage|December 17, 2002
Wavelet-aided parametric mapping of cerebral dopamine D2 receptors using the high affinity PET radioligand [11C]FLB 457Zsolt Cselényi, Hans Olsson, Lars Farde, et al.
Clinical Breast Cancer|July 2, 2013
Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survivalIvan Shabo, Hans Olsson, Olle Stål, et al.
BJU International|July 6, 2023
Bladder cancer grading using the four-tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classificationsStaffan Jahnson, Georg Jancke, Hans Olsson, et al.
Scandinavian Journal of Urology|September 8, 2012
Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumoursHans Olsson, Per Hultman, Johan Rosell, et al.
Lakartidningen|December 7, 2007
[Results following implementation of PCI in Varmland. 30-day mortality after myocardial infarction halved]Tage Nilsson, Hans Olsson, Johan Lugnegård, et al.
International Journal of Cancer|July 8, 2009
Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival timeIvan Shabo, Hans Olsson, Xiao-Feng Sun, et al.
Scandinavian Journal of Urology and Nephrology|December 14, 2011
HER2 status in primary stage T1 urothelial cell carcinoma of the urinary bladderHans Olsson, Ing-Marie Fyhr, Per Hultman, et al.
Pageof 8